Johnson T J, Quigley E M, Adrian T E, Jin G, Rikkers L F
Department of Surgery, University of Nebraska Medical Center, Omaha 68198-2000, USA.
Dig Dis Sci. 1995 Aug;40(8):1816-23. doi: 10.1007/BF02212707.
Glucagon has been proposed as the mediator of splanchnic hyperemia in portal hypertension. Employing an assay specific for pancreatic glucagon, we reevaluated the relationship between this peptide and portal hypertension in the portal vein (PV)-stenosed rat model addressing, in particular, the effects of anesthesia and surgical stress. Plasma glucagon levels were similar in sham-operated and portal hypertensive rats: glucagon, sham vs PV stenosed: 110.7 +/- 17.1 pmol/liter vs 140.6 +/- 23.3 pmol/liter (NS). Furthermore, plasma levels of glucagon and the related peptide VIP were not significantly influenced by anesthesia or surgical stress, and levels remained similar under all conditions in sham-operated and PV-stenosed animals. We conclude that pancreatic glucagon is not elevated in the PV-stenosed rat; differences between these results and those describing hyperglucagonemia in this model cannot be explained on the basis of a differential response to stress but may reflect differences in glucagon assay system.
胰高血糖素被认为是门静脉高压时内脏充血的介质。我们采用一种针对胰高血糖素的检测方法,在门静脉(PV)狭窄的大鼠模型中重新评估了这种肽与门静脉高压之间的关系,特别探讨了麻醉和手术应激的影响。假手术组大鼠和门静脉高压大鼠的血浆胰高血糖素水平相似:胰高血糖素,假手术组与PV狭窄组:110.7±17.1 pmol/升 vs 140.6±23.3 pmol/升(无显著性差异)。此外,胰高血糖素和相关肽血管活性肠肽(VIP)的血浆水平不受麻醉或手术应激的显著影响,在假手术组和PV狭窄组动物的所有条件下,其水平均保持相似。我们得出结论,在PV狭窄的大鼠中,胰高血糖素水平并未升高;这些结果与该模型中描述高胰高血糖素血症的结果之间的差异,不能基于对应激的不同反应来解释,而可能反映了胰高血糖素检测系统的差异。